{"disease":{"id":"acne","name":"Acne","therapeutic_area":"Dermatology","data":{"aiSummary":"The acne treatment landscape includes a variety of topical and systemic therapies. Topical retinoids and benzoyl peroxide are first-line treatments for comedonal and mild inflammatory acne. For moderate to severe acne, oral antibiotics and/or isotretinoin are often necessary. Recent advances include new topical retinoids like trifarotene and clascoterone, a topical androgen receptor inhibitor. The pipeline includes new formulations and devices, such as enhanced laser platforms, aimed at improving efficacy and patient outcomes.","drug_count":5,"description":"Acne is a chronic inflammatory skin condition characterized by the formation of comedones, papules, pustules, nodules, and cysts. It primarily affects the pilosebaceous units, leading to inflammation and potential scarring. The pathophysiology involves excess sebum production, follicular hyperkeratinization, bacterial colonization (Cutibacterium acnes), and inflammation. Current treatments range from topical agents to systemic medications, addressing various aspects of the disease.","subtype_count":10},"enrichment_level":2,"last_enriched_at":null,"visit_count":0,"created_at":"2026-03-25T12:16:34.901Z","updated_at":"2026-03-25T12:16:34.901Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":0,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"clindamycin-phosphate","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cleocin T","generic_name":"CLINDAMYCIN PHOSPHATE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"Lincosamide Antibacterial","quality_score":51,"revenue":null,"mechanism":"Cleocin T works by inhibiting protein synthesis in bacteria, preventing them from producing essential proteins and ultimately leading to cell death."},{"drug_id":"clascoterone","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Winlevi","generic_name":"CLASCOTERONE","company_name":"Sun Pharma","drug_phase":"marketed","molecular_target":"Androgen receptor","drug_class":"Androgen Receptor Inhibitor [EPC]","quality_score":48,"revenue":null,"mechanism":"Winlevi works by blocking the androgen receptor, a protein that helps regulate hormones in the body."},{"drug_id":"cleanser","indication_name":"Acne Treatment","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cleanser","company_name":"Dr.dr.Irma Bernadette, SpKK (K)","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":7,"revenue":null,"mechanism":null},{"drug_id":"cleanser","indication_name":"Prevention of New Acne Blemishes","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cleanser","company_name":"Dr.dr.Irma Bernadette, SpKK (K)","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":7,"revenue":null,"mechanism":null},{"drug_id":"isotretinoin","indication_name":"Severe Recalcitrant Nodular Acne","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Accutane","generic_name":"ISOTRETINOIN","company_name":"","drug_phase":"marketed","molecular_target":"Retinoic acid receptor alpha","drug_class":"Retinoid [EPC]","quality_score":60,"revenue":null,"mechanism":""},{"drug_id":"dapsone-gel","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"dapsone gel","company_name":"Almirall, S.A.","drug_phase":"marketed","molecular_target":"","drug_class":"Sulfone [EPC]","quality_score":13,"revenue":null,"mechanism":null},{"drug_id":"doxycycline","indication_name":"Severe acne","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vibramycin","generic_name":"doxycycline","company_name":"Generic (originally Pfizer)","drug_phase":"marketed","molecular_target":"72 kDa type IV collagenase, Stromelysin-1, Collagenase 3","drug_class":"Tetracycline antibiotic","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"fusidic-acid","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ramycin","generic_name":"FUSIDIC ACID","company_name":"","drug_phase":"phase_3","molecular_target":"Bile salt export pump","drug_class":"fusidic acid","quality_score":47,"revenue":null,"mechanism":"Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins."},{"drug_id":"doxycyclin","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Doxycyclin","company_name":"Bulovka Hospital","drug_phase":"marketed","molecular_target":"72 kDa type IV collagenase, Stromelysin-1, Collagenase 3","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"ferrous-fumarate","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Iron Fumarate","generic_name":"FERROUS FUMARATE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"Vitamin C [EPC]","quality_score":37,"revenue":null,"mechanism":""},{"drug_id":"norethisterone","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Micronor","generic_name":"norethisterone","company_name":"Johnson & Johnson","drug_phase":"marketed","molecular_target":"GnRH receptors","drug_class":"Progestin","quality_score":63,"revenue":null,"mechanism":"ORIAHNN combines elagolix, which suppresses LH and FSH to reduce ovarian sex hormones, with estradiol and norethindrone acetate to mitigate side effects."},{"drug_id":"differin","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"differin","company_name":"University of Magdeburg","drug_phase":"marketed","molecular_target":"Aspartate aminotransferase, cytoplasmic, Glycine receptor subunit alpha-1, Retinoic acid receptor alpha","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"nicotinamide","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Infuvite Adult","generic_name":"Nicotinamide","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"NAD-dependent protein deacetylase sirtuin-2","drug_class":"Standardized Chemical Allergen [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"estradiol","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Estrace","generic_name":"ESTRADIOL","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Estrogen receptor","drug_class":"Estrogen","quality_score":69,"revenue":null,"mechanism":"Estrace works by binding to estrogen receptors in the body, mimicking the effects of natural estrogen."},{"drug_id":"azelaic-acid","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Azelex","generic_name":"AZELAIC ACID","company_name":"Leo Pharma As","drug_phase":"marketed","molecular_target":"3-oxo-5-alpha-steroid 4-dehydrogenase 2","drug_class":"azelaic acid","quality_score":51,"revenue":null,"mechanism":"Azelex works by inhibiting the enzyme 3-oxo-5-alpha-steroid 4-dehydrogenase 2, which is involved in the production of androgens that contribute to acne and rosacea."},{"drug_id":"clindamycin-phosphate","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cleocin T","generic_name":"CLINDAMYCIN PHOSPHATE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"Lincosamide Antibacterial","quality_score":51,"revenue":null,"mechanism":"Cleocin T works by inhibiting protein synthesis in bacteria, preventing them from producing essential proteins and ultimately leading to cell death."},{"drug_id":"benzoyl-peroxide","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Benzamycin","generic_name":"BENZOYL PEROXIDE","company_name":"Mayne Pharma","drug_phase":"marketed","molecular_target":"","drug_class":"benzoyl peroxide","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"norethindrone-acetate","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aygestin","generic_name":"NORETHINDRONE ACETATE","company_name":"Duramed Res","drug_phase":"marketed","molecular_target":"Progesterone receptor","drug_class":"Estrogen [EPC]","quality_score":46,"revenue":null,"mechanism":""},{"drug_id":"sulfacetamide","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Klaron","generic_name":"SULFACETAMIDE","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Dihydrofolate reductase","drug_class":"Sulfonamide Antibacterial","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"dapsone","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aczone","generic_name":"DAPSONE","company_name":"Almirall","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 6","drug_class":"Sulfone [EPC]","quality_score":65,"revenue":null,"mechanism":"Aczone works by inhibiting bacterial growth and reducing inflammation through its sulfone properties."},{"drug_id":"clindamycin","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cleocin","generic_name":"clindamycin","company_name":"Generic (originally Upjohn/Pfizer)","drug_phase":"marketed","molecular_target":"50S ribosomal protein L10","drug_class":"Lincosamide antibiotic","quality_score":56,"revenue":null,"mechanism":"Lincosamide antibiotic that binds the 50S ribosomal subunit, inhibiting bacterial protein synthesis with excellent anaerobic coverage."},{"drug_id":"clascoterone","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Winlevi","generic_name":"CLASCOTERONE","company_name":"Sun Pharma","drug_phase":"marketed","molecular_target":"Androgen receptor","drug_class":"Androgen Receptor Inhibitor [EPC]","quality_score":48,"revenue":null,"mechanism":"Winlevi works by blocking the androgen receptor, a protein that helps regulate hormones in the body."},{"drug_id":"cortisone-acetate","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortone","generic_name":"CORTISONE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"amphotericin-b","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Abelcet","generic_name":"AMPHOTERICIN B","company_name":"Astellas Pharma","drug_phase":"marketed","molecular_target":"","drug_class":"Lipid-based Polyene Antifungal [EPC]","quality_score":49,"revenue":null,"mechanism":""},{"drug_id":"adapalene","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Differin","generic_name":"ADAPALENE","company_name":"Galderma Labs Lp","drug_phase":"marketed","molecular_target":"Retinoic acid receptor beta","drug_class":"Retinoid [EPC]","quality_score":51,"revenue":null,"mechanism":"Differin works by binding to retinoic acid receptors on the skin's surface, which helps to prevent clogged pores and reduce inflammation."},{"drug_id":"ammonia","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ammonia","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Radioactive Diagnostic Agent [EPC]","quality_score":19,"revenue":null,"mechanism":""},{"drug_id":"aklief","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"AKLIEF®","company_name":"Teva Pharmaceuticals USA","drug_phase":"marketed","molecular_target":"Retinoic acid receptor alpha, Retinoic acid receptor beta, Retinoic acid receptor gamma","drug_class":"","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"erythromycin","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"E-Mycin","generic_name":"erythromycin","company_name":"Generic (originally Abbott/Lilly)","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, Bile salt export pump, Cytochrome P450 1B1","drug_class":"Macrolide [EPC]","quality_score":27,"revenue":null,"mechanism":""},{"drug_id":"nadifloxacin","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nadixa","generic_name":"NADIFLOXACIN","company_name":"","drug_phase":"phase_3","molecular_target":"","drug_class":"nadifloxacin","quality_score":32,"revenue":null,"mechanism":"Nadixa works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication and transcription."},{"drug_id":"benzamycin","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Benzamycin","generic_name":"benzamycin","company_name":"","drug_phase":"unknown","molecular_target":"Potassium voltage-gated channel subfamily H member 2","drug_class":"Macrolide","quality_score":null,"revenue":null,"mechanism":"Benzamycin works by interacting with potassium channels to modulate their function."},{"drug_id":"tretinoin","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Retin-A","generic_name":"TRETINOIN","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Nuclear receptor ROR-beta","drug_class":"Retinoid [EPC]","quality_score":58,"revenue":null,"mechanism":"Tretinoin works by binding to and activating nuclear receptors, which helps to regulate cell growth and differentiation."},{"drug_id":"tretinoin","indication_name":"Severe Recalcitrant Nodular Acne","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Retin-A","generic_name":"TRETINOIN","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Nuclear receptor ROR-beta","drug_class":"Retinoid [EPC]","quality_score":58,"revenue":null,"mechanism":"Tretinoin works by binding to and activating nuclear receptors, which helps to regulate cell growth and differentiation."},{"drug_id":"meclocycline","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Meclan","generic_name":"MECLOCYCLINE","company_name":"Johnson And Johnson","drug_phase":"marketed","molecular_target":"","drug_class":"meclocycline","quality_score":19,"revenue":null,"mechanism":""},{"drug_id":"finacea","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Finacea","company_name":"Actavis Inc.","drug_phase":"marketed","molecular_target":"3-oxo-5-alpha-steroid 4-dehydrogenase 2","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"estrone","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Estron","generic_name":"ESTRONE","company_name":"Watson Labs","drug_phase":"marketed","molecular_target":"Estrogen receptor","drug_class":"estrone","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"motretinide","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tasmadem","generic_name":"MOTRETINIDE","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"motretinide","quality_score":null,"revenue":null,"mechanism":"Tasmadem works by inhibiting the production of sebum, a key factor in the development of acne."},{"drug_id":"hydrocortisone","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortef","generic_name":"hydrocortisone","company_name":"Generic (originally Merck/Upjohn)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"Corticosteroid [EPC]","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"ethinylestradiol","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ortho-Novum 10/11-21","generic_name":"Ethinylestradiol","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Estrogen receptor","drug_class":"Estrogen","quality_score":38,"revenue":null,"mechanism":""},{"drug_id":"estring","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Estring","generic_name":"Estradiol","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Ovulation","drug_class":"Combined Oral Contraceptive (COC)","quality_score":71,"revenue":null,"mechanism":"Prevents pregnancy primarily by suppressing ovulation."},{"drug_id":"drospirenone","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Slynd","generic_name":"DROSPIRENONE","company_name":"Exeltis Usa Inc","drug_phase":"marketed","molecular_target":"Mineralocorticoid receptor","drug_class":"Progestin","quality_score":75,"revenue":null,"mechanism":"Slynd works by binding to the mineralocorticoid receptor, a protein that plays a role in hormone regulation."},{"drug_id":"sulfur","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"SULFUR","company_name":"Poythress","drug_phase":"marketed","molecular_target":"Carbonic anhydrase 1","drug_class":"sulfur","quality_score":27,"revenue":null,"mechanism":""},{"drug_id":"sulfur","indication_name":"Acneiform eruption","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"SULFUR","company_name":"Poythress","drug_phase":"marketed","molecular_target":"Carbonic anhydrase 1","drug_class":"sulfur","quality_score":27,"revenue":null,"mechanism":""},{"drug_id":"erythrocin","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Benzamycin","generic_name":"Erythromycin Lactobionate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Potassium voltage-gated channel subfamily H member 2","drug_class":"Macrolide","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"isotretinoin","indication_name":"Severe Recalcitrant Nodular Acne","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Accutane","generic_name":"ISOTRETINOIN","company_name":"","drug_phase":"marketed","molecular_target":"Retinoic acid receptor alpha","drug_class":"Retinoid [EPC]","quality_score":60,"revenue":null,"mechanism":""},{"drug_id":"loteprednol","indication_name":"acne rosacea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Loteprednol Etabonate","generic_name":"LOTEPREDNOL","company_name":"Bausch And Lomb","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"minocycline","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Minocycline Hydrochloride","generic_name":"MINOCYCLINE","company_name":"Rempex","drug_phase":"marketed","molecular_target":"","drug_class":"Tetracycline-class Drug","quality_score":75,"revenue":null,"mechanism":"MINOCYCLINE works by inhibiting protein synthesis in bacteria, ultimately leading to their death."},{"drug_id":"doxycycline","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vibramycin","generic_name":"doxycycline","company_name":"Generic (originally Pfizer)","drug_phase":"marketed","molecular_target":"72 kDa type IV collagenase, Stromelysin-1, Collagenase 3","drug_class":"Tetracycline antibiotic","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"cortisol","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cortisol","company_name":"University of Zurich","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"metafolin","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Metafolin","company_name":"University of California, San Diego","drug_phase":"marketed","molecular_target":"Thymidylate synthase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"benoxyl","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Benoxyl","company_name":"Aier School of Ophthalmology, Central South University","drug_phase":"phase_2","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"resorcinol","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"resorcinol","company_name":"","drug_phase":"unknown","molecular_target":"Carbonic anhydrase 12, Carbonic anhydrase 14, Carbonic anhydrase 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"resorcinol","indication_name":"Acneiform eruption","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"resorcinol","company_name":"","drug_phase":"unknown","molecular_target":"Carbonic anhydrase 12, Carbonic anhydrase 14, Carbonic anhydrase 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"adapalen","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Adapalen","company_name":"Technische Universität Dresden","drug_phase":"marketed","molecular_target":"Aspartate aminotransferase, cytoplasmic, Glycine receptor subunit alpha-1, Retinoic acid receptor alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"minocyclin","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Minocyclin","company_name":"University of Southern California","drug_phase":"marketed","molecular_target":"30S ribosomal protein S4, 30S ribosomal protein S9, Tetracycline resistance protein, class B","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":54,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02349399","title":"Drug Utilization Study on Diane-35 (and Generics) in Three European Healthcare Databases","phase":"","overall_status":"COMPLETED","enrollment_count":26065,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT05247333","title":"Implementation of a Minor Ailment Service in Community Pharmacy Practice","phase":"NA","overall_status":"COMPLETED","enrollment_count":20987,"lead_sponsor_name":"Universidad de Granada","has_results":false},{"nct_id":"NCT04538703","title":"Social Media Use of Acne Vulgaris Patients: Multicenter, Survey Work","phase":"","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"Istanbul Medeniyet University","has_results":false},{"nct_id":"NCT05483205","title":"Normaderm Phytosolution Global Observational Study","phase":"","overall_status":"COMPLETED","enrollment_count":2827,"lead_sponsor_name":"Cosmetique Active International","has_results":false},{"nct_id":"NCT05601960","title":"A Combination Treatment Reduces Acne Severity and PIHP","phase":"","overall_status":"COMPLETED","enrollment_count":1785,"lead_sponsor_name":"Cosmetique Active International","has_results":false},{"nct_id":"NCT00422240","title":"Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1668,"lead_sponsor_name":"Galderma R&D","has_results":true},{"nct_id":"NCT03615768","title":"A Study to Evaluate the Efficacy and Safety of Adapalene-Clindamycin Combination Gel in the Treatment of Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1617,"lead_sponsor_name":"Lee's Pharmaceutical Limited","has_results":false},{"nct_id":"NCT04538729","title":"Use of Alternative Therapy in Acne Vulgaris Patients","phase":"","overall_status":"COMPLETED","enrollment_count":1571,"lead_sponsor_name":"Istanbul Medeniyet University","has_results":false},{"nct_id":"NCT03271021","title":"A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1488,"lead_sponsor_name":"Vyne Therapeutics Inc.","has_results":true},{"nct_id":"NCT00280657","title":"Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne Papulopustulosa","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1326,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04134273","title":"Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":1260,"lead_sponsor_name":"Sun Pharmaceutical Industries, Inc.","has_results":false},{"nct_id":"NCT03717506","title":"Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1236,"lead_sponsor_name":"Balmoral Medical company","has_results":true},{"nct_id":"NCT02566369","title":"Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1208,"lead_sponsor_name":"Galderma R&D","has_results":true},{"nct_id":"NCT04015375","title":"Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1150,"lead_sponsor_name":"Torrent Pharmaceuticals Limited","has_results":false},{"nct_id":"NCT03132194","title":"Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":1125,"lead_sponsor_name":"Sun Pharmaceutical Industries, Inc.","has_results":false},{"nct_id":"NCT03522441","title":"Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1125,"lead_sponsor_name":"Akorn, Inc.","has_results":true},{"nct_id":"NCT02886715","title":"A Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both to a Placebo Control in the Treatment of Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1110,"lead_sponsor_name":"Fougera Pharmaceuticals Inc.","has_results":true},{"nct_id":"NCT07469228","title":"A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne Vulgaris","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":1043,"lead_sponsor_name":"Sun Pharmaceutical Industries, Inc.","has_results":false},{"nct_id":"NCT02322866","title":"Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1034,"lead_sponsor_name":"Almirall, S.A.","has_results":true},{"nct_id":"NCT04724473","title":"A Study Comparing Tretinoin Cream 0.025% and RETIN-A® Cream 0.025% in the Treatment of Acne Vulgaris","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":1030,"lead_sponsor_name":"Sun Pharmaceutical Industries, Inc.","has_results":false},{"nct_id":"NCT04031469","title":"A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease","phase":"","overall_status":"SUSPENDED","enrollment_count":1000,"lead_sponsor_name":"ProgenaBiome","has_results":false},{"nct_id":"NCT06733402","title":"A Study Comparing Trifarotene Cream 0.005% to AKLIEF® CREAM (US REFERENCE LISTED DRUG), AKLIEF™ CREAM (CANADIAN REFERENCE PRODUCT) in the Treatment of Acne Vulgaris","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Sun Pharmaceutical Industries, Inc.","has_results":false},{"nct_id":"NCT04797793","title":"A Study Comparing Adapalene Gel 0.1% and to Differin Gel in the Treatment of Acne Vulgaris","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":978,"lead_sponsor_name":"Sun Pharmaceutical Industries, Inc.","has_results":false},{"nct_id":"NCT04883736","title":"A Study Comparing Tretinoin Gel Microsphere, 0.1% and RETIN-A MICRO ® Gel Microsphere, 0.1% in the Treatment of Acne Vulgaris","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":973,"lead_sponsor_name":"Sun Pharmaceutical Industries, Inc.","has_results":false},{"nct_id":"NCT02320149","title":"Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":968,"lead_sponsor_name":"Almirall, S.A.","has_results":true},{"nct_id":"NCT03393494","title":"Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the Face","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":825,"lead_sponsor_name":"Padagis LLC","has_results":true},{"nct_id":"NCT02965456","title":"Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":820,"lead_sponsor_name":"Bausch Health Americas, Inc.","has_results":true},{"nct_id":"NCT02932306","title":"Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":820,"lead_sponsor_name":"Bausch Health Americas, Inc.","has_results":true},{"nct_id":"NCT03168321","title":"A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (301)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":813,"lead_sponsor_name":"Bausch Health Americas, Inc.","has_results":true},{"nct_id":"NCT05550337","title":"Study Comparing Trifarotene Cream, 0.005% To AKLIEF ® (Trifarotene 0.005% Cream) In The Treatment Of Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":807,"lead_sponsor_name":"Teva Pharmaceuticals USA","has_results":true},{"nct_id":"NCT03168334","title":"A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (302)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":801,"lead_sponsor_name":"Bausch Health Americas, Inc.","has_results":true},{"nct_id":"NCT01445301","title":"Study STF115287, a Clinical Confirmation Study of GSK2585823 in the Treatment of Acne Vulgaris in Japanese Subjects","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":800,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT06063473","title":"A Study Comparing Trifarotene Cream 0.005% to AKLIEF® Cream in the Treatment of Acne Vulgaris","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":762,"lead_sponsor_name":"Sun Pharmaceutical Industries, Inc.","has_results":false},{"nct_id":"NCT03028363","title":"A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":759,"lead_sponsor_name":"Dermira, Inc.","has_results":true},{"nct_id":"NCT02410031","title":"Risk Minimisation Study for Diane-35 and Its Generics","phase":"","overall_status":"COMPLETED","enrollment_count":759,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT03650361","title":"Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":755,"lead_sponsor_name":"Aleor Dermaceuticals Limited","has_results":false},{"nct_id":"NCT03127956","title":"A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":748,"lead_sponsor_name":"Dermira, Inc.","has_results":true},{"nct_id":"NCT03073486","title":"A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":744,"lead_sponsor_name":"Dermira, Inc.","has_results":true},{"nct_id":"NCT01017120","title":"A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":742,"lead_sponsor_name":"Stiefel, a GSK Company","has_results":true},{"nct_id":"NCT03170388","title":"A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":741,"lead_sponsor_name":"Bausch Health Americas, Inc.","has_results":true},{"nct_id":"NCT02608476","title":"A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":732,"lead_sponsor_name":"Cassiopea SpA","has_results":true},{"nct_id":"NCT05982613","title":"Effectiveness of Standard Therapy of Acne Vulgaris","phase":"","overall_status":"COMPLETED","enrollment_count":724,"lead_sponsor_name":"Indonesia University","has_results":false},{"nct_id":"NCT02608450","title":"A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":708,"lead_sponsor_name":"Cassiopea SpA","has_results":true},{"nct_id":"NCT03433378","title":"To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne Vulgaris","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":700,"lead_sponsor_name":"Sun Pharmaceutical Industries, Inc.","has_results":false},{"nct_id":"NCT07457294","title":"1% Clascoterone Cream for the Treatment Acne Vulgaris","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":692,"lead_sponsor_name":"Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.","has_results":false},{"nct_id":"NCT04892706","title":"Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel and Vehicle Gel","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":686,"lead_sponsor_name":"Bausch Health Americas, Inc.","has_results":true},{"nct_id":"NCT01320033","title":"Placebo Controlled Efficacy and Safety Study of CD2475/101 40 mg Tablets vs. Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions of Acne Vulgaris","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":662,"lead_sponsor_name":"Galderma R&D","has_results":true},{"nct_id":"NCT02682264","title":"An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":609,"lead_sponsor_name":"Cassiopea SpA","has_results":true},{"nct_id":"NCT03664739","title":"Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":608,"lead_sponsor_name":"Bausch Health Americas, Inc.","has_results":true},{"nct_id":"NCT04925180","title":"A Study to Learn About the Awareness and Knowledge That Doctors Have About the Safety and Safe Use Information for Androcur and Other Cyproterone Acetate Treatments in Europe","phase":"","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"Bayer","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}